Alzheon attracts $10 mln Series A
Framingham, Massachusetts-based Alzheon Inc, a biopharmaceutical company focused on brain health, memory and aging, has secured $10 million in Series A funding. Ally Bridge Group led the round.
8 April 2015•3 mins read
